Ying Liang

Ying Liang

Auto-generated profile, based on publicly available information

Ying Liang

Shanghai Public Health Clinical Center and Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute and Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2014 in BMC Cancer
Verified
Journal Article
Open access
PDF file
ICI Che Chung
I Che Chung
LCLih-Chyang Chen
Lih-Chyang Chen
ACAn-Ko Chung
An-Ko Chung
MCMei Chao
Mei Chao
HHHsin-Yi Huang
Hsin-Yi Huang
YCYu-Sun Chang
Yu-Sun Chang
Overexpression of heterogeneous nuclear ribonucleoprotein K (hnRNP K), a DNA/RNA binding protein, is associated with metastasis in nasopharyngeal carcinoma (NPC). However, the mechanisms underlying hnRNP K-mediated metastasis is unclear. The aim of the present study was to determine the role of matrix metalloproteinase (MMP) in hnRNP K-mediated metastasis in NPC.

4 September 2017 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
YLYing Liang
Ying Liang
QZQingping Zou
Qingping Zou
WYWenqiang Yu
Wenqiang Yu
MicroRNAs (miRNAs) are a class of endogenous non-coding RNAs with regulatory functions. Traditionally, miRNAs are thought to play a negative regulatory role in the cytoplasm by binding to the 3′UTR of target genes to degrade mRNA or inhibit translation. However, it remains a challenge to interpret the potential function of many miRNAs located in the nucleus. Recently, we reported a new type of miRNAs present in the nucleus, which can activate gene expression by binding to the enhancer, and named them nuclear activating miRNAs (NamiRNAs). The discovery of NamiRNAs showcases a complementary regulatory mechanism of miRNA, demonstrating their differential roles in the nucleus and cytoplasm. Here, we reviewed miRNAs in nucleus to better understand the function of NamiRNAs in their interactions with the enhancers. Accordingly, we propose a NamiRNA–enhancer–target gene activation network model to better understand the crosstalk between NamiRNAs and enhancers in regulating gene transcription. Moreover, we hypothesize that NamiRNAs may be involved in cell identity or cell fate determination during development, although further study is needed to elucidate the underlying mechanisms in detail.

1 August 2019 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
YLYing Liang
Ying Liang
PXPeng Xu
Peng Xu
QZQingping Zou
Qingping Zou
HLHuaibing Luo
Huaibing Luo
WYWenqiang Yu
Wenqiang Yu

1 August 2022 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
YLYing Liang
Ying Liang
PXPeng Xu
Peng Xu
QZQingping Zou
Qingping Zou
HLHuaibing Luo
Huaibing Luo
WYWenqiang Yu
Wenqiang Yu

5 November 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
WLWei Li
Wei Li
SYShuai Yang
Shuai Yang
PXPeng Xu
Peng Xu
DZDapeng Zhang
Dapeng Zhang
YTYing Tong
Ying Tong
WYWenqiang Yu
Wenqiang Yu
SUMMARY: The COVID-19 pandemic is a widespread and deadly public health crisis. The pathogen SARS-CoV-2 replicates in the lower respiratory tract and causes fatal pneumonia. Although tremendous efforts have been put into investigating the pathogeny of SARS-CoV-2, the underlying mechanism of how SARS-CoV-2 interacts with its host is largely unexplored. Here, by comparing the genomic sequences of SARS-CoV-2 and human, we identified five fully conserved elements in SARS-CoV-2 genome, which were termed as “human identical sequences (HIS)”. HIS are also recognized in both SARS-CoV and MERS-CoV genome. Meanwhile, HIS-SARS-CoV-2 are highly conserved in the primate. Mechanically, HIS-SARS-CoV-2, behaving as virus-derived miRNAs, directly target to the human genomic loci and further interact with host enhancers to activate the expression of adjacent and distant genes, including cytokines gene and angiotensin converting enzyme II ( ACE2 ), a well-known cell entry receptor of SARS-CoV-2, and hyaluronan synthase 2 ( HAS2 ), which further increases hyaluronan formation. Noteworthily, hyaluronan level in plasma of COVID-19 patients is tightly correlated with severity and high risk for acute respiratory distress syndrome (ARDS) and may act as a predictor for the progression of COVID-19. HIS antagomirs, which downregulate hyaluronan level effectively, and 4-Methylumbelliferone (MU), an inhibitor of hyaluronan synthesis, are potential drugs to relieve the ARDS related ground-glass pattern in lung for COVID-19 treatment. Our results revealed that unprecedented HIS elements of SARS-CoV-2 contribute to the cytokine storm and ARDS in COVID-19 patients. Thus, blocking HIS-involved activating processes or hyaluronan synthesis directly by 4-MU may be effective strategies to alleviate COVID-19 progression.